Stress proteins as inducers and targets of regulatory T cells in arthritis

International Reviews of Immunology

Volumn 24, Issue 3-4, 2005, Pages 181-197

  Van Eden, Willem ^a   Hauet Broere, Femke ^a   Berlo, Suzanne ^a   Paul, Liesbeth ^a   Van Der Zee, Ruurd ^a   De Kleer, Isme ^b   Prakken, Berent ^b   Taams, Leonie ^c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Arthritis; Heat shock protein (HSP); IL 10; Stress proteins; T cells

Indexed keywords

ANTIGEN; CD4 ANTIGEN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; OM 89; SALBUTAMOL;

ARTHRITIS; AUTOIMMUNITY; CYTOKINE PRODUCTION; DISEASE RESISTANCE; HUMAN; IMMUNIZATION; JUVENILE RHEUMATOID ARTHRITIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REMISSION; REVIEW; T LYMPHOCYTE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; HEAT-SHOCK PROTEINS; INTERLEUKIN-10; T-LYMPHOCYTES;

EID: 22244474265     PISSN: 08830185     EISSN: None     Source Type: Journal    
DOI: 10.1080/08830180590934958     Document Type: Review

References (60)

1. R.J. Ellis, The molecular chaperone concept, Semin. Cell. Biol., 1: 1-9, 1990.
2. W.J. Welch, How cells respond to stress, Sci. Am., 268: 56-64, 1993.
3. L. Mizzen, Immune responses to stress proteins: applications to infectious disease and cancer. Biotherapy, 10: 173-189, 1998.
4. J.S. Gaston, Heat shock proteins and arthritis-new readers start here, Autoimmunity, 26: 33-42, 1997.
5. A. De Maio, Heat shock proteins: facts, thoughts, and dreams, Shock, 11: 1-12, 1999.
6. D. Przepiorka and P.K. Srivastava, Heat shock protein-peptide complexes as immunotherapy for human cancer, Mol. Med. Today, 4: 478-84, 1998.
7. R.M. Vabulas, P. Ahmad-Nejad, C. da Costa, T. Miethke, C.J. Kirschning, H. Hacker, and H. Wagner, Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells, J. Biol. Chem., 276: 31332-9, 2001.
8. R.M. Vabulas, P. Ahmad-Nejad, S. Ghose, C.J. Kirschning, R.D. Issels, and H. Wagner, HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway, J. Biol. Chem., 277: 15107-12, 2002.
9. K. Ohashi, V. Burkart, S. Flohe, and H. Kolb, Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex, J. Immunol., 164: 558-61, 2000.
10. W. Chen, U. Syldath, K. Bellmann, V. Burkart, and H. Kolb, Human 60-kDa heat-shock protein: a danger signal to the innate immune system, J. Immunol., 162: 3212-9, 1999.
11. P. Matzinger, Tolerance, danger, and the extended family, Annu. Rev. Immunol., 12: 991-1045, 1994.
12. R. Suto and P.K. Srivastava, A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides, Science, 269: 1585-8, 1995.
13. R.J. Binder, K.M. Anderson, S. Basu, and P.K. Srivastava, Cutting edge: heat shock protein gp96 induces maturation and migration of CD11c+ cells in vivo, J. Immunol., 165: 6029-35, 2000.
14. I.R. Cohen, Kadishman's tree, Escher's angels, and the immunological homunculus, Isr. J. Med. Sci., 32: 44-50, 1996.
15. W. van Eden, J.E. Thole, R. van der Zee, A. Noordzij, J.D. van Embden, E.J. Hensen, and I.R. Cohen, Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis, Nature, 331: 171-3, 1988.
16. W. van Eden, Heat-shock proteins as immunogenic bacterial antigens with the potential to induce and regulate autoimmune arthritis, Immunol. Rev., 121: 5-28, 1991.
17. R. Ulmansky, C.J. Cohen, F. Szafer, E. Moallem, Z.G. Fridlender, Y. Kashi, and Y. Naparstek, Resistance to adjuvant arthritis is due to protective antibodies against heat shock protein surface epitopes and the induction of IL-10 secretion, J. Immunol., 168: 6463-9, 2002.
18. A. Bloemendal, R. Van der Zee, V.P. Rutten, P.J. van Kooten, J.C. Farine, and W. van Eden, Experimental immunization with anti-rheumatic bacterial extract OM-89 induces T cell responses to heat shock protein (hsp)60 and hsp70; modulation of peripheral immunological tolerance as its possible mode of action in the treatment of rheumatoid arthritis (RA), Clin. Exp. Immunol., 110: 72-8, 1997.
19. P.M. Cobelens, C.J. Heijnen, E.E. Nieuwenhuis, P.P. Kramer, R. van der Zee, W. van Eden, and A. Kavelaars, Treatment of adjuvant-induced arthritis by oral administration of mycobacterial Hsp65 during disease, Arthritis. Rheum., 43: 2694-702, 2000.
20. P.M. Cobelens, A. Kavelaars, A. Vroon, M. Ringeling, R. van der Zee, W. van Eden, and C.J. Heynen, The beta(2)-adrenergic agonist salbutamol potentiates oral induction of tolerance, suppressing adjuvant arthritis and antigen-specific immunity, J. Immunol., 169: 5028-35, 2002.
21. S.M. Anderton, R. van der Zee, A. Noordzij, and W. van Eden, Differential mycobacterial 65-kDa heat shock protein T cell epitope recognition after adjuvant arthritis-inducing or protective immunization protocols, J. Immunol., 152: 3656-64, 1994.
22. S.M. Anderton, R. van der Zee, B. Prakken, A. Noordzij, and W. van Eden, Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis, J. Exp. Med., 181: 943-52, 1995.
23. U. Wendling, L. Paul, R. van der Zee, B. Prakken, M. Singh, and W. van Eden, A conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue, J. Immunol., 164: 2711-7, 2000.
24. A.G. Paul, R. van Der Zee, L.S. Taams, and W. van Eden, A self-hsp60 peptide acts as a partial agonist inducing expression of B7-2 on mycobacterial hsp60-specific T cells: a possible mechanism for inhibitory T cell regulation of adjuvant arthritis? Int. Immunol., 12: 1041-50, 2000.
25. W. van Eden, R. van der Zee, A.G. Paul, B.J. Prakken, U. Wendung, S.M. Anderton, and M.H. Wauben, Do heat shock proteins control the balance of T-cell regulation in inflammatory diseases? Immunol. Today, 19: 303-7, 1998.
26. A.G. Paul, P.J. van Kooten, W. van Eden, and R. van der Zee, Highly autoproliferative T cells specific for 60-kDa heat shock protein produce IL-4/IL-10 and IFN-gamma and are protective in adjuvant arthritis, J. Immunol., 165: 7270-7, 2000.
27. L.S. Taams, A.J. van Rensen, M.C. Poelen, C.A. van Els, A.C. Besseling, J.P. Wagenaar, W. van Eden, and M.H. Wauben, Anergic T cells actively suppress T cell responses via the antigen-presenting cell, Eur. J. Immunol., 28: 2902-12, 1998.
28. L.S. Taams, W. van Eden, and M.H. Wauben, Dose-dependent induction of distinct anergic phenotypes: multiple levels of T cell anergy, J. Immunol., 162: 1974-81, 1999.
29. J.G. Chai, I. Bartok, P. Chandler, S. Vendetti, A. Antoniou, J. Dyson, and R. Lechler, Anergic T cells act as suppressor cells in vitro and in vivo, Eur. J. Immunol., 29: 686-92, 1999.
30. M. Wills-Karp, J. Santeliz, and C.L. Karp, The germless theory of allergie disease: revisiting the hygiene hypothesis, Nat. Rev. Immunol., 1: 69-75, 2001.
31. A.H. van den Biggelaar, R. van Ree, L.C. Rodrigues, B. Lell, A.M. Deelder, P.G. Kremsner, and M. Yazdanbakhsh, Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10, Lancet, 356: 1723-7, 2000.
32. Y. Yi, X. Yang, and R.C. Brunham, Autoimmunity to heat shock protein 60 and antigen-specific production of interleukin-10, Infect Immun., 65: 1669-74, 1997.
33. + T cells during rat listeriosis, Int. Immunol., 10: 117-30, 1998.
34. P. Stordeur and M. Goldman, Interleukin-10 as a regulatory cytokine induced by cellular stress: molecular aspects, Int. Rev. Immunol., 16: 501-22, 1998.
35. A.G. van Halteren, B. Mosselman, B.O. Roep, W. van Eden, A. Cooke, G. Kraal, and M.H. Wauben, T cell reactivity to heat shock protein 60 in diabetes-susceptible and genetically protected nonobese diabetic mice is associated with a protective cytokine profile, J. Immunol., 165: 5544-51, 2000.
36. U. Wendling, L. Paul, R. van Der Zee, B. Prakken, M. Singh, and W. van Eden, A conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue, J. Immunol., 164: 2711-2717, 2000.
37. B.J. Prakken, U. Wendling, R. van der Zee, V.P. Rutten, W. Kuis, and W. van Eden, Induction of IL-10 and inhibition of experimental arthritis are specific features of microbial heat shock proteins that are absent for other evolutionarily conserved immunodominant proteins, J. Immunol., 167: 4147-53, 2001.
38. B.J. Prakken, S. Roord, P.J. van Kooten, J.P. Wagenaar, W. van Eden, S. Albani, and M.H. Wauben, Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60T cell epitope, Arthritis Rheum., 46: 1937-46, 2002.
39. P. Woo and L.R. Wedderburn, Juvenile chronic arthritis, Lancet, 351: 969-73, 1998.
40. I.M. de Kleer, L.R. Wedderburn, L.S. Taams, A. Patel, H. Varsani, M. Klein, W. de Jager, G. Pugayung, F. Giannoni, G. Rijkers, S. Albani, W. Kuis, and B. Prakken, CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis, J. Immunol., 172: 6435-43, 2004.
41. B. Prakken, W. Kuis, W. Van Eden, and S. Albani, Heat shock proteins in juvenile idiopathic arthritis: keys for understanding remitting arthritis and candidate antigens for immune therapy, Curr. Rheumatol. Rep., 4: 466-73, 2002.
42. C.J. Boog, E.R. de Graeff-Meeder, M.A. Lucassen, R. van der Zee, M.M. Voorhorst-Ogink, P.J. van Kooten, H.J. Geuze, and W. van Eden, Two monoclonal antibodies generated against human hsp60 show reactivity with synovial membranes of patients with juvenile chronic arthritis, J. Exp. Med., 175: 1805-10, 1992.
43. E.R. de Graeff-Meeder, G.T. Rijkers, M.M. Voorhorst-Ogink, W. Kuis, R. van der Zee, W. van Eden, and B.J. Zegers, Antibodies to human HSP60 in patients with juvenile chronic arthritis, diabetes mellitus, and cystic fibrosis, Pediatr. Res., 34: 424-8, 1993.
44. E.R. De Graeff-Meeder, R. van der Zee, G.T. Rijkers, H.J. Schuurman, W. Kuis, J.W. Bijlsma, B.J. Zegers, and W. van Eden, Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis, Lancet, 337: 1368-72, 1991.
45. P. Life, A. Hassell, K. Williams, S. Young, P. Bacon, T. Southwood, and J.S. Gaston, Responses to gram negative enteric bacterial antigens by synovial T cells from patients with juvenile chronic arthritis: recognition of heat shock protein HSP60, J. Rheumatol., 20: 1388-96, 1993.
46. E.R. de Graeff-Meeder, W. van Eden, G.T. Rijkers, B.J. Prakken, W. Kuis, M.M. Voorhorst-Ogink, R. van der Zee, H.J. Schuurman, P.J. Helders, and B.J. Zegers, Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favorable course of arthritis, J. Clin. Invest., 95: 934-40, 1995.
47. I.M. de Heer, S.M. Kampuis, G.T. Rijkers, L. Scholtens, G. Gordon, W. De Jager, R. Hafner, R. van de Zee, W. van Eden, W. Kuis, and B.J. Prakken, The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10, Arthritis Rheum, 48: 2001-10, 2003.
48. F.J. Quintana, P. Carmi, F. Mor, and I.R. Cohen, Inhibition of adjuvant arthritis by a DNA vaccine encoding human heat shock protein 60, J. Immunol., 169: 3422-8, 2002.
49. B. Prakken, M. Wauben, D. Genini, R. Samodal, J. Barnett, A. Mendivil, L. Leoni, and S. Albani, Artificial antigen-presenting cells as a tool to exploit the immune 'synapse', Nat. Med., 6: 1406-10, 2000.
50. A.B. Prakken, M.J. van Hoeji, W. Kuis, A. Kavelaars, C.J. Heynen, E. Scholtens, I.M. de Kleer, G.T. Rijkers, and W. van Eden, T-cell reactivity to human HSP60 in oligo-articular juvenile chronic arthritis is associated with a favorable prognosis and the generation of regulatory cytokines in the inflamed joint, Immunol. Lett., 57: 139-42, 1997.
51. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance, Immunol. Rev., 182: 18-32, 2001.
52. + suppressor T cells, Immunol. Rev., 182: 58-67, 2001.
53. L.A. Stephens, C. Mottet, D. Mason, and F. Powrie, Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro, Eur. J. Immunol., 31: 1247-54, 2001.
54. L.S. Taams, J. Smith, M.H. Rustin, M. Salmon, L.W. Poulter, and A.N. Akbar, Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population, Eur. J. Immunol., 31: 1122-31, 2001.
55. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state, Int. Immunol., 10: 1969-80, 1998.
56. + regulatory T cells, Eur. J. Immunol., 32: 1621-30, 2002.
57. R.S. McHugh, M.J. Whitters, C.A. Piccirillo, D.A. Young, E.M. Shevach, M. Collins, and M.C. Byrne, CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor, Immunity, 16: 311-23, 2002.
58. + regulatory T cells through GITR breaks immunological self-tolerance, Nat. Immunol., 2002.
59. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10, J. Immunol., 166: 3008-18, 2001.
60. + regulatory T cells. Their role in the control of superantigen responses, Immunol. Rev., 182: 180-9, 2001.